158 related articles for article (PubMed ID: 15465274)
1. Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition.
Richter-Landsberg C; Bauer NG
Int J Dev Neurosci; 2004 Nov; 22(7):443-51. PubMed ID: 15465274
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid.
Goldbaum O; Oppermann M; Handschuh M; Dabir D; Zhang B; Forman MS; Trojanowski JQ; Lee VM; Richter-Landsberg C
J Neurosci; 2003 Oct; 23(26):8872-80. PubMed ID: 14523089
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment of ubiquitin to tau-positive aggregates in oligodendrocytes in culture.
Goldbaum O; Richter-Landsberg C
J Neurosci; 2004 Jun; 24(25):5748-57. PubMed ID: 15215297
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
6. Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.
Dabir DV; Trojanowski JQ; Richter-Landsberg C; Lee VM; Forman MS
Am J Pathol; 2004 Jan; 164(1):155-66. PubMed ID: 14695329
[TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress.
Riedel M; Goldbaum O; Richter-Landsberg C
J Mol Neurosci; 2009 Sep; 39(1-2):226-34. PubMed ID: 19266322
[TBL] [Abstract][Full Text] [Related]
8. Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration.
Richter-Landsberg C
Biol Chem; 2016 Mar; 397(3):185-94. PubMed ID: 26083267
[TBL] [Abstract][Full Text] [Related]
9. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
[TBL] [Abstract][Full Text] [Related]
10. αB-crystallin and HSP27 in glial cells in tauopathies.
López-González I; Carmona M; Arregui L; Kovacs GG; Ferrer I
Neuropathology; 2014 Dec; 34(6):517-26. PubMed ID: 24985029
[TBL] [Abstract][Full Text] [Related]
11. The dynamic instability of microtubules is required for aggresome formation in oligodendroglial cells after proteolytic stress.
Bauer NG; Richter-Landsberg C
J Mol Neurosci; 2006; 29(2):153-68. PubMed ID: 16954605
[TBL] [Abstract][Full Text] [Related]
12. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases.
Seiberlich V; Goldbaum O; Zhukareva V; Richter-Landsberg C
Biochim Biophys Acta; 2012 Nov; 1823(11):2057-68. PubMed ID: 22565157
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
Wilhelmus MM; de Jager M; Rozemuller AJ; Brevé J; Bol JG; Eckert RL; Drukarch B
J Pathol; 2012 Jan; 226(1):132-42. PubMed ID: 22009441
[TBL] [Abstract][Full Text] [Related]
14. Exon 3 insert of tau protein in neurodegenerative diseases.
Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
16. The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.
Richter-Landsberg C
J Mol Neurosci; 2008 May; 35(1):55-63. PubMed ID: 18058074
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes.
Goldbaum O; Vollmer G; Richter-Landsberg C
Glia; 2006 Jun; 53(8):891-901. PubMed ID: 16609961
[TBL] [Abstract][Full Text] [Related]
18. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
19. Tau-based treatment strategies in neurodegenerative diseases.
Schneider A; Mandelkow E
Neurotherapeutics; 2008 Jul; 5(3):443-57. PubMed ID: 18625456
[TBL] [Abstract][Full Text] [Related]
20. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
Newman J; Rissman RA; Sarsoza F; Kim RC; Dick M; Bennett DA; Cotman CW; Rohn TT; Head E
Acta Neuropathol; 2005 Aug; 110(2):135-44. PubMed ID: 15986225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
